Founded in 1993
  Year: 2009 | Volume: 17 | Issue: 3-4 | Pages: 61-64
  Review Article
Vesna Ivanovic
  DOI: 10.2298/AOO0904061I
  Transforming growth factor-b (TGF-b), an extensively investigated cytokine, plays a very important role in promoting the spread of cancers in the body, and can play a direct role in facilitating metastasis. Consequently, TGF-b is currently explored as a prognostic candidate biomarker of tumor invasiveness and metastasis. Therefore, in clinical scenarios involving increased TGF-b activity, attempts to decrease or abrogate TGF-b signaling could be used as a therapy for advanced or metastatic disease. It follows that TGF-b signaling offers an attractive target for cancer therapy. Several anti-TGF-b approaches, such as TGF-b antibodies, antisense oligonucleotides and small molecules inhibitors of TGF-b type 1 receptor kinase, have shown great promise in the preclinical studies. These studies, coupled with progressing clinical trials indicate that inhibition of TGF-b signaling may be indeed a viable option to cancer therapy. This review summarizes the TGF-b biology, screening cancer patients for anti-TGF-b therapy, and several strategies targeted against TGF-b signaling for cancer therapy. The next several years promise to improve our understanding of approaching cancer therapy by further evaluation of TGF-b signaling inhibitors for clinical efficacy. The complexity of TGF-b biology guarantees that many surprises lie ahead.
  Key words: Transforming Growth Factor beta; Signal Transduction; Neoplasms
  Read full text in PDF [Full Text]
Next article

Previous article

Table of contents

Browse all Volumes

Search all Volumes
By keywords
By authors

  Search AoO for:

  Related articles in AoO:
About Journal | Editorial Board | Editorial Policy | Instructions for Authors | Open Access | Advertising | Payed issues | Article Submission Charge | Contact
Founder, owner and publisher: Oncology Institute of Vojvodina, Serbia
Online since 1997 (Abstracts only); 2000 (Abstracts and Full text)
ISSN: 0354-7310 eISSN: 1450-9520